Oblimersen in Treating Patients With Merkel Cell Carcinoma

Summary

This phase II trial is studying how well oblimersen works in treating patients with Merkel cell cancer. Biological therapies, such as oblimersen, may interfere with the growth of tumor cells and slow the growth of Merkel cell carcinoma (skin cancer).

Timeline

Start

2004-01

Primary completion

2007-01

Completion

—

Drugs

Indications